TECH
HOLD / NEUTRALMeanRevComposite
56.50
Technical
88.90
Fundamental
45.70
Rank
—
Price
71.90
Hurst
0.27
As of
Aug 7, 2026
Daily
Bio-Techne Corporation
HealthcareBiotechnologyBio-Techne Corporation develops and manufactures biological reagents, diagnostic products, and analytical instruments for research, clinical diagnostics, and bioprocessing applications across various life science markets. Its Protein Sciences segment produces reagents such as antibodies, cytokines, and growth factors, along with protein analysis instruments for research and diagnostics. The Diagnostics and Spatial Biology segment offers diagnostic assays, tissue analysis tools, and quality control products for clinical laboratories and genomic research.
Market cap
$11.4B
P/E (trailing)
62.42
P/E (forward)
31.40
PEG ratio
2.11
Dividend yield
44.00%
Beta
1.28
52w range
43.20 – 72.62
Return on equity
+9.03%
Profit margin
+14.97%
Revenue growth
+1.30%
Earnings growth
—
Price history
1Y: 72.41 (+37.4%) · range 43.17–72.47
Cycle position
56/ 100 cycle scoreMID-BULL
ENTRYAPPROACHMID-BULLNEAR-TOPEXIT
entry readiness 12 · NOT READY · exit proximity 0
Conviction
24/ 100 · maturity 100%
VScore.4013
Buildup.2045
EMA entry setup.2512
Fundamentals.1546
Volume profile
POC
72.28
Price vs POC
+0.2%
Overhead supply
6%
Runway
open sky
Value area 55.47–72.58 · 6% of 120d volume overhead · clean runway
Contributing sources
| Source | Score | Last seen |
|---|---|---|
| financial-news | 0.414 | Sep 2, 2026 |
| earnings-surprise | 0.015 | Sep 10, 2026 |
Forward returns
| Horizon | Return | MFE | State |
|---|---|---|---|
| 20d | +0.06% | +0.06% | 1/20d |
| 40d | +0.06% | +0.06% | 1/40d |